Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients

Completed · Phase 2

Conditions studied: Venous Thromboembolism

In brief

Three month treatment of acute VTE with Fragmin in pediatric cancer patients

Key facts

Study ID
NCT00952380
Run by
Pfizer
People needed
38
Starts
2009-08-01
Expected to finish
2018-03-01
Last updated by the study team
2019-04-16

Who can join

Age: any, up to 18. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.